News

Federated Hermes Sets Date for Fourth Quarter Earnings Call

Federated Hermes Sets Date for Fourth Quarter Earnings Call

Federated Hermes Schedules Earnings Release for 2024

Federated Hermes, Inc. (NYSE: FHI), a leader in active investing, is preparing to announce its financial results for the fourth quarter and the full year ending 2024. Interested investors can expect the announcement to be made after market close on Thursday. This information is pivotal for shareholders and analysts who follow the company’s performance closely.

Details of the Earnings Conference Call

The company will hold a conference call with investors and analysts to discuss these results on the following day, Friday, at 9 a.m. Eastern Time. The call will be hosted by President and CEO J. Christopher Donahue alongside Chief Financial Officer Thomas R. Donahue. They will delve into the company's performance, giving insights that elucidate trends and outcomes from the past year.

How to Join the Conference Call

For those wanting to listen in on this important discussion, you can dial in either domestically or internationally. The domestic call-in number is 888-506-0062, while international participants can connect using 973-528-0011. Alternatively, interested listeners can visit the company’s official website for real-time access to the call. It is recommended to join the call at least 15 minutes early to facilitate registration and connection.

Accessing the Replay

Should you miss the live call, don’t worry! A telephone replay will be available shortly after the event, commencing around 12:30 p.m. Eastern on Friday. To access the replay, call 877-481-4010 if you are domestic or 919-882-2331 if you're calling internationally, using access code 51862. Furthermore, the online replay will be available on Federated Hermes' website for the duration of one year, allowing ample time for investors to catch up on the insights shared.

About Federated Hermes, Inc.

Federated Hermes, Inc. stands out in the realm of investment management, boasting an impressive $800.5 billion in assets under its management as of late September. The firm is dedicated to providing diverse investment solutions, tailored to achieve multiple financial outcomes for a wide variety of clients, including corporations, foundations, and government entities. Their extensive offerings encompass equity, fixed income, alternative markets, and liquidity management strategies, ensuring they meet the needs of more than 10,000 institutions globally.

Global Presence and Commitment to Investors

Headquartered in Pittsburgh, Federated Hermes employs more than 2,000 staff members across major cities including London, New York, and Boston. Their global presence underpins their commitment to deliver significant value and innovative solutions to clients worldwide. The company’s ethos revolves around active, responsible management, making them a trusted partner in the investment landscape.

Frequently Asked Questions

What are the upcoming important dates for Federated Hermes?

Federated Hermes will announce its financial results after market close on a Thursday, followed by a conference call the next day for analysis and insights.

Who will host the earnings call?

The earnings call will be hosted by President and CEO J. Christopher Donahue and CFO Thomas R. Donahue.

How can I access the earnings call?

You can participate by dialing either the domestic number 888-506-0062 or international number 973-528-0011. Alternatively, access is available online via their website.

Is there a replay of the earnings call available?

Yes, a replay will be accessible starting 12:30 p.m. Eastern the same day, with a one-year availability online.

What does Federated Hermes offer in terms of investment management?

Federated Hermes offers a variety of investment solutions across equity, fixed income, and alternative markets tailored for over 10,000 clients worldwide, ensuring comprehensive financial support.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vylor's $3 Billion Buyback: A Long-Term Bet

Updated Category News Views 3

Pumping Confidence with a Massive Buyback Vylor's big move to throw $3 billion into a share buyback isn't about short-term antics. This company's doubling down on long-term value creation, making sure every stakeholder knows they're in for the long haul. It's a gutsy move but what this step really tells us is, they've got faith in the business and a balance sheet that can...

Continue Reading
Vertice P2P Aims to Transform Procurement Efficiency

Updated Category News Views 10

Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 3

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 2

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
2026 Merkin Prize Champions Cochlear Implant Innovators

Updated Category News Views 4

Sometimes, the world flips its script. In 2026, five fearless innovators grabbed the spotlight at the Broad Institute. If you're not familiar with Graeme Clark, Erwin and Ingeborg Hochmair, Michael Merzenich, or Blake Wilson, well then, you've been snoozing under a rock. These folks were decorated with the prestigious Merkin Prize for crafting the modern cochlear...

Continue Reading
Papa John's Faces Securities Lawsuit Amid 17.18% Stock Drop

Updated Category News Views 1

Papa John's Legal Trouble and Stock Tumble Lemme paint you a picture: Papa John's International, Inc. just walked smack dab into the middle of a courtroom drama it's not too eager to star in. The lawsuit's hot on their trail after a sharp 17.18% plummet in their stock price. As far as the markets go, that's a nosedive that'll smack the paint off any seasoned investor's...

Continue Reading
Haystack Expands MCP to Boost AI Intranet Workflow

Updated Category News Views 8

Bridging the Intranet and AI: A Game Changer? You ever feel like your company's intranet is a black hole, swallowing all the information you need before spitting it back out in a chaos of outdated pages and broken links? Well, Haystack aims to clear that fog with their Model Context Protocol (MCP) server. And starting October 26, the game takes a leap forward. Now, not...

Continue Reading
Hanwha Power Gets ABS Green Light for Electric Ship

Updated Category News Views 2

Breaking New Ground in Maritime Electrification In the world of shipping, Hanwha Power's latest move could be a game-changer. They've landed Approval in Principle from the American Bureau of Shipping (ABS) for a groundbreaking fully electric containership design. Coming straight out of Seoul, this news shook up the maritime crowd in Bergen, Norway, at the recent MHE...

Continue Reading
Bambu Lab Shakes Up 3D Printing with Massive Discounts

Updated Category News Views 5

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Continue Reading
QUA's EnviQ RF 30: A Game-Changer in Water Reuse

Updated Category News Views 4

Revolutionizing Water Treatment with Compact Solutions When you walk into a wastewater treatment facility, the last thing you expect is elegance. But elegance in efficiency is exactly what QUA is bringing to the table with their new EnviQ RF 30 compact membrane unit. This isn't your average pipe dream—it's a full-blown reality shaping the future of water reuse. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Martha Larsen Honored by Inner Circle for Real Estate Impact

Updated Category News Views 11

Saluting a Real Estate Maverick: Martha Larsen's Latest Accolade If you've been hustling in the residential real estate game, you know standing out these days ain't a small feat. But here comes Martha Larsen, blazing through industry awards like they're going out of style, now celebrated by The Inner Circle for being an ace of aces. Not just another tick on her awards...

Continue Reading
Investigation Launched for Arvinas, Inc. Investors Amid Concerns

Updated Category News Views 394

Pomerantz Law Firm Investigates Arvinas, Inc. Pomerantz LLP, a prominent law firm renowned for its expertise in securities litigation, is currently conducting an investigation focused on the interests of investors in Arvinas, Inc. (NASDAQ: ARVN). This inquiry seeks to identify any potential misdeeds or unlawful activities that may have occurred within the company. What...

Continue Reading
Jim Cramer Highlights Energy Stocks and Market Insights

Updated Category News Views 59

Jim Cramer stirred the pot on energy stocks during his stint on CNBC's “Mad Money Lightning Round.” He gave a thumbs-up to VICI Properties Inc. (NYSE: VICI), stating it’s 'fine' for investment—good news for those holding the bag or thinking about dipping in. But hold on, this isn’t just a simple endorsement; you gotta keep your eyes peeled as they were about to...

Continue Reading
Terex Merges with REV Group to Become Industry Leader

Updated Category News Views 119

Terex and REV Group Merger: A New Era in Specialty Equipment Terex Corporation has announced a groundbreaking merger with REV Group, marking the dawn of a new premier specialty equipment manufacturer. This merger is expected to significantly strengthen both companies’ positions in diverse markets, especially given the combined portfolio and promising growth prospects....

Continue Reading
Exciting Advances in Gene Therapy for Heart Failure Unveiled

Updated Category News Views 161

Significant Developments in Gene Therapy for Heart Failure Research Triangle Park, N.C. — AskBio Inc., a leading gene therapy entity and a subsidiary of Bayer AG, is thrilled to announce pivotal insights from the 12-month Phase 1 trial of its investigational gene therapy AB-1002. This therapy, designed for individuals grappling with congestive heart failure (CHF), has...

Continue Reading